EUVIMEDEUVIMED entdecken
Crossref

Beyond symptom reduction: DMT improves anxiety, life satisfaction, and quality of life in healthy volunteers and patients with depression

Raynara Bolcont, Fernanda Palhano-Fontes iD, Handersson Barros iD, Sophie Laborde iD, Daniel Amorim iD, Marcelo Falchi-Carvalho iD, Nicole Galvão-Coelho, Isabel Wießner iD, Draulio B Araujo iD

Journal of Psychopharmacology · 2026

DOI: 10.1177/02698811261465005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Psychopharmacology, 2026. Verfasst von Raynara Bolcont und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil. Hauptthemen laut MEDLINE: Quality of Life, Anxiety, Personal Satisfaction, N,N-Dimethyltryptamine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recent studies have demonstrated rapid antidepressant effects of inhaled N,N -dimethyltryptamine (DMT); however, long-term effects, including broader well-being dimensions, are sparsely explored across populations.

Aims

Investigating whether DMT produces sustained improvements in anxiety, life satisfaction, and quality of life, in both healthy individuals and patients with treatment-resistant depression (TRD).

Methods

In 2 open-label clinical trials, 27 healthy individuals and 14 patients with TRD, respectively, received inhaled DMT in a supportive clinical setting. Repeated assessments were conducted from baseline up to 12 months (only patients), including state anxiety (State-Trait Anxiety Inventory State, STAI-S), life satisfaction (Satisfaction with Life Scale, SWL), and quality of life (World Health Organization Quality of Life Instrument – Abbreviated Version, WHOQOL-BREF, and Spirituality, Religion and Personal Beliefs Module, WHOQOL-SRPB).

Results

All volunteers showed reduced state anxiety after inhalation up to 1 day afterward. Healthy volunteers reported increased life satisfaction up to 14 days post-administration. Beyond symptom reduction, patients reported increased life satisfaction after 12 months and sustained improvements in quality of life over that period, including Physical Health, Psychological Health, Social Relationships, and Environment (WHOQOL-BREF), and partially Inner Peace and Hope & Optimism (WHOQOL-SRPB).

Conclusion

These findings suggest that inhaled DMT, combined with psychological support, is associated with recovery of daily functioning and health domains in patients with depression. Although limited by open-label design, lacking placebo control, and modest sample size, this exploratory study highlights the value of incorporating multidimensional outcomes in psychedelic research and DMT’s potential relevance in both clinical and public health contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeAnxietyPersonal SatisfactionN,N-DimethyltryptamineDepressive Disorder, Treatment-ResistantAntidepressive AgentsHumansMaleFemaleAdultMiddle AgedAdministration, InhalationHealthy VolunteersYoung Adult

Stichwörter der Autor:innen

N, N-dimethyltryptamineanxietydepressionlife satisfactionquality of lifetreatment-resistant depression

Substanzen

N,N-DimethyltryptamineAntidepressive Agents

Autor:innen und Institutionen

  • Graduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
  • Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil.
  • Department of Clinical Medicine, Health Science Center, Federal University of Rio Grande do Norte, Natal, Brazil.
  • Department of Physiology and Behavior, Federal University of Rio Grande do Norte, Natal, Brazil.

ORCID-Profile: Fernanda Palhano-Fontes, Handersson Barros, Sophie Laborde, Daniel Amorim, Marcelo Falchi-Carvalho, Isabel Wießner, Draulio B Araujo

Zitieren

APA

Bolcont, R., Palhano-Fontes, F., Barros, H., Laborde, S., Amorim, D., Falchi-Carvalho, M., Galvão-Coelho, N., Wießner, I., & Araujo, D. B. (2026). Beyond symptom reduction: DMT improves anxiety, life satisfaction, and quality of life in healthy volunteers and patients with depression. Journal of Psychopharmacology. https://doi.org/10.1177/02698811261465005

Vancouver

Bolcont R, Palhano-Fontes F, Barros H, Laborde S, Amorim D, Falchi-Carvalho M, et al. Beyond symptom reduction: DMT improves anxiety, life satisfaction, and quality of life in healthy volunteers and patients with depression. Journal of Psychopharmacology. 2026. doi:10.1177/02698811261465005

BibTeX
@article{Bolcont2026,
  author = {Bolcont, Raynara and Palhano-Fontes, Fernanda and Barros, Handersson and Laborde, Sophie and Amorim, Daniel and Falchi-Carvalho, Marcelo and Galvão-Coelho, Nicole and Wießner, Isabel and Araujo, Draulio B},
  title = {Beyond symptom reduction: DMT improves anxiety, life satisfaction, and quality of life in healthy volunteers and patients with depression},
  journal = {Journal of Psychopharmacology},
  year = {2026},
  doi = {10.1177/02698811261465005}
}
Kostenlos starten →